These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 1962615
1. Acid suppression as treatment for NSAID-related peptic ulcers. Howden CW, Holt S. Am J Gastroenterol; 1991 Dec; 86(12):1720-2. PubMed ID: 1962615 [No Abstract] [Full Text] [Related]
3. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy. Lanas A, Remacha B, Sáinz R, Hirschowitz BI. Am J Gastroenterol; 2000 Feb 30; 95(2):513-9. PubMed ID: 10685760 [Abstract] [Full Text] [Related]
7. Omeprazole or misoprostol. Which works best for NSAID-induced ulcers? Gautam M, Por CP, Evans MF. Can Fam Physician; 1998 Aug 30; 44():1629-31. PubMed ID: 9721418 [No Abstract] [Full Text] [Related]
8. Role of acid suppressants in prophylaxis of NSAID damage. Chan FK, Sung JJ. Best Pract Res Clin Gastroenterol; 2001 Jun 30; 15(3):433-45. PubMed ID: 11403537 [Abstract] [Full Text] [Related]
9. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs. Guslandi M. N Engl J Med; 1998 Jul 30; 339(5):350; author reply 350-1. PubMed ID: 9696651 [No Abstract] [Full Text] [Related]
10. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?]. Lanas Arbeloa A, Serrano Aulló MT. Gastroenterol Hepatol; 1998 Jan 30; 21 Suppl 1():20-4. PubMed ID: 9549198 [No Abstract] [Full Text] [Related]
12. [Antisecretory drugs and prophylaxis of secondary gastrointestinal effects associated with the consumption of non steroid anti-inflammatory drugs]. Lanas A, Arroyo MT. Med Clin (Barc); 2000 Jan 30; 114 Suppl 2():57-62. PubMed ID: 10916808 [Abstract] [Full Text] [Related]
13. Misoprostol vs omeprazole for ulcers associated with NSAIDs. Bell AD. Can Fam Physician; 1998 Nov 30; 44():2371-2. PubMed ID: 9839045 [No Abstract] [Full Text] [Related]
14. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy. Scheiman JM. Am J Manag Care; 2001 Feb 30; 7(1 Suppl):S10-4. PubMed ID: 11225347 [Abstract] [Full Text] [Related]
15. [The influence of non-steroidal anti-inflammatory drugs (NSAID) in the treatment of peptic ulcer. A prospective randomized study]. Manniche C, Malchow-Møller A. Ugeskr Laeger; 1987 Aug 03; 149(32):2143-4. PubMed ID: 3329789 [No Abstract] [Full Text] [Related]
16. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine. Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL. Am J Gastroenterol; 2002 Sep 03; 97(9):2208-14. PubMed ID: 12358234 [Abstract] [Full Text] [Related]
17. Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data. Talley NJ. Am J Med; 1998 Mar 30; 104(3A):62S-66S; discussion 79S-80S. PubMed ID: 9572323 [No Abstract] [Full Text] [Related]
18. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs]. Stock KP, Bach GL. Z Rheumatol; 1988 Mar 30; 47(3):177-81. PubMed ID: 3213266 [Abstract] [Full Text] [Related]
19. [New approach to the treatment and prophylaxis of NSAID-induced gastropathies in ambulatory practics]. Burkov SG, Arutiunov AT, Nikiforov PA. Eksp Klin Gastroenterol; 2007 Mar 30; (5):96-102. PubMed ID: 18389605 [No Abstract] [Full Text] [Related]